Neurology® Podcast cover image

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Neurology® Podcast

00:00

Multiple Sclerosis - Hit Hard Early?

Frederick: I think there has been a lot of interest in myosynia replicating that journey. If you look at the multiple sclerosis treatment tools we have they exert an effect as long as you give the drug. So something that seems attractive is to do induction treatment with drugs that permanently eliminates certain cell populations. Multiple sclerosis came years after rheumatoid arthritis butMyosynia is lagging behind. Gordon: It's important to start thinking about treatment already at diagnosis and make a plan for how to treat long term because you risk missing a treatment opportunity.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app